Tech Center 1600 • Art Units: 1611 1617 1629
This examiner grants 24% of resolved cases
Elizabeth Anne Meyers, in Tech Center 1600 and Art Unit 1611, has 17 resolved cases. The allowance rate is 23.5 percent, but the interview lift is a very high 92.9 percent. This 92.9 percent lift is extremely significant compared to the 23.5 percent baseline. The 23.5 percent allowance rate is low, but the 92.9 percent lift suggests that interviews are the most effective way to get a case allowed.
The median days to allowance is 1128. While the 23.5 percent allowance rate is challenging, the 92.9 percent interview lift is a powerful tool for applicants. Counsel should be prepared for a 1128 day timeline and should always request an interview. With only 17 resolved cases, the data is limited but clear on the value of interviews. The 1128 day pendency and 92.9 percent lift are the defining characteristics of prosecution with this examiner. Utilizing the 92.9 percent lift is essential for success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18743381 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | Final Rejection | The Procter & Gamble Company |
| 18318805 | HAIR CONDITIONER COMPOSITIONS CONTAINING NON-SILICONE CONDITIONING AGENTS | Non-Final OA | The Procter & Gamble Company |
| 18841637 | ENDOSOMAL CLEAVABLE HYDROPHILIC-MASKED CATIONIC CHARGE DELIVERY VEHICLES | Non-Final OA | The Regents of the University of California |
| 18688943 | AN ORAL CARE COMPOSITION COMPRISING A GLYCOLIPID AND A MILD SURFACTANT | Final Rejection | BASF SE |
| 17756872 | DIETARY BUTYRATE AND ITS USES | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18580076 | COMPOSITIONS WITH MICROENCAPSULATED ACETAMIDE AND METAL-CHELATED MESOTRIONE | Final Rejection | MONSANTO TECHNOLOGY LLC |
| 18859858 | ANIMAL FOOD COMPOSITION COMPRISING A SOURCE OF GLYCYRRHIZIN | Non-Final OA | MARS, INCORPORATED |
| 18278903 | MICRONEEDLES AND METHODS FOR TREATING THE SKIN | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18580498 | Method For Spot-Treatment Application Against Weeds | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
| 18688180 | COMPOSITIONS AND METHODS FOR TREATING BONE INJURIES | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17795099 | SUSTAINED-RELEASE MATRICES FOR ADVENTITIAL OR PERIADVENTITIAL NEURAL ABLATION AND USES THEREOF | Final Rejection | W. L. Gore & Associates, Inc. |
| 18838780 | Fumaric Acid Esters, Inhalation Administration Methods, Pharmaceutical Uses and Compositions | Non-Final OA | Arizona Board of Regents on behalf of the University of Arizona |
| 18073969 | MULTILEVEL ANTIMICROBIAL POLYMERIC COLLOIDS AND DEVICE SCREENS CONTAINING SAME | Non-Final OA | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 18490618 | HAIR TREATMENT COMPOSITION WITH CATIONIC SURFACTANT, FATTY ALCOHOLS, AND LOW POLAR OIL | Non-Final OA | L'OREAL |
| 18552540 | COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS | Non-Final OA | L'OREAL |
| 18232587 | COMPOSITIONS AND METHODS FOR HAIR | Non-Final OA | L'OREAL |
| 18231735 | COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS | Final Rejection | L'Oreal |
| 18265540 | COMPOSITION FOR CLEANSING KERATIN MATERIALS | Non-Final OA | L'OREAL |
| 18115247 | COMPOSITIONS AND METHODS FOR CURLY HAIR | Non-Final OA | L'Oreal |
| 18559842 | POWDERY CLEANSING COMPOSITION | Non-Final OA | BEIERSDORF AG |
| 18001738 | FRAGRANCE-STABLE COSMETIC PREPARATION | Final Rejection | BEIERSDORF AG |
| 17595855 | Surface Modified Gas Vesicles, Preparation and Applications thereof | Non-Final OA | THE HONG KONG POLYTECHNIC UNIVERSITY |
| 18566247 | PLACENTA-MIMIC COSMETIC COMPOSITION | Non-Final OA | LG HOUSEHOLD & HEALTH CARE LTD. |
| 17639699 | Cosmetic Composition Comprising Solid Phase Polymer Components Having Improved Solubility | Final Rejection | LG Household & Health Care Ltd. |
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | Non-Final OA | LTS LOHMANN THERAPIE-SYSTEME AG |
| 18538047 | COMPOSITION CONTAINING RECOMBINANT COLLAGEN WITH REPAIRING AND SOOTHING EFFECTS, EYE CREAM CONTAINING THE COMPOSITION AND PREPARATION METHOD THEREOR | Final Rejection | MAYINGLONG MASSIVE HEALTH CO., LTD |
| 18246405 | HYDROXYAPATITE COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRUS INFECTION | Final Rejection | DR. KURT WOLFF GMBH & CO. KG |
| 18233659 | ORAL ACTIVE AGENT DELIVERY SYSTEM FOR ANIMALS AND METHOD | Final Rejection | BIRD DOG BIOVENTURES, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy